Free. Unsubscribe any time.
CUMBERLAND PHARMACEUTICALS INC (CPIX)
CUMBERLAND PHARMACEUTICALS INC filed 38 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 483 transactions and 9,914 shares. None carries the SEC's AFF10B5ONE flag; all 38 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-01-06, came on the same day as the one before it (2026-01-06) and reports 22 transactions against 22 in the filing before it.
- Its 38 plan statements rank 1st of the 2 companies the register carries in Tennessee, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 38 filings on file run from 2025-04-04 to 2026-01-06, and state one plan adoption date, 2024-11-14.
Trades in CUMBERLAND PHARMACEUTICALS INC 483
- Jones James — 2025-03-03 · P · 10 shares
- Krogulski Kenneth — 2025-03-03 · P · 47 shares
- Young Caroline — 2025-03-03 · P · 4 shares
- Jones James — 2025-03-04 · P · 10 shares
- Krogulski Kenneth — 2025-03-04 · P · 47 shares
- Young Caroline — 2025-03-04 · P · 4 shares
- Jones James — 2025-03-05 · P · 10 shares
- Krogulski Kenneth — 2025-03-05 · P · 47 shares
- Young Caroline — 2025-03-05 · P · 4 shares
- Jones James — 2025-03-06 · P · 10 shares
- Krogulski Kenneth — 2025-03-06 · P · 47 shares
- Young Caroline — 2025-03-06 · P · 4 shares
Adoption dates in CUMBERLAND PHARMACEUTICALS INC 1
- 2024-11-14 — stated in 38 filings
Results prints in CUMBERLAND PHARMACEUTICALS INC 7
- 2025-03-04
- 2025-05-06
- 2025-08-05
- 2025-11-04
- 2026-03-03
- 2026-05-05
- 2026-08-04
Trades before a print in CUMBERLAND PHARMACEUTICALS INC 38
- 0 days before the 2025-03-04 print — 2025-03-04 · P · Jones James · 10 shares
- 0 days before the 2025-03-04 print — 2025-03-04 · P · Krogulski Kenneth · 47 shares
- 0 days before the 2025-03-04 print — 2025-03-04 · P · Young Caroline · 4 shares
- 0 days before the 2025-05-06 print — 2025-05-06 · P · Jones James · 8 shares
- 0 days before the 2025-05-06 print — 2025-05-06 · P · KAZIMI A J · 8 shares
- 0 days before the 2025-05-06 print — 2025-05-06 · P · Krogulski Kenneth · 45 shares
- 0 days before the 2025-05-06 print — 2025-05-06 · P · Young Caroline · 4 shares
- 0 days before the 2025-08-05 print — 2025-08-05 · P · Jones James · 13 shares
- 0 days before the 2025-08-05 print — 2025-08-05 · P · KAZIMI A J · 13 shares
- 0 days before the 2025-08-05 print — 2025-08-05 · P · Krogulski Kenneth · 68 shares
- 0 days before the 2025-08-05 print — 2025-08-05 · P · Young Caroline · 6 shares
- 1 day before the 2025-03-04 print — 2025-03-03 · P · Jones James · 10 shares
Interval to CUMBERLAND PHARMACEUTICALS INC’s next reported results date
How the interval and sources are counted →
- 38within 5 days
- 62within 10 days
- 0shortest, days
- 0no later print
- Jones James 2025-03-03 · P · 1 day before the 2025-03-04 print
- Krogulski Kenneth 2025-03-03 · P · 1 day before the 2025-03-04 print
- Young Caroline 2025-03-03 · P · 1 day before the 2025-03-04 print
- Jones James 2025-03-04 · P · 0 days before the 2025-03-04 print
- Krogulski Kenneth 2025-03-04 · P · 0 days before the 2025-03-04 print
- Young Caroline 2025-03-04 · P · 0 days before the 2025-03-04 print
- Jones James 2025-04-28 · P · 8 days before the 2025-05-06 print
- KAZIMI A J 2025-04-28 · P · 8 days before the 2025-05-06 print · Chairman and CEO
- Krogulski Kenneth 2025-04-28 · P · 8 days before the 2025-05-06 print
- Young Caroline 2025-04-28 · P · 8 days before the 2025-05-06 print
- Jones James 2025-04-29 · P · 7 days before the 2025-05-06 print
- KAZIMI A J 2025-04-29 · P · 7 days before the 2025-05-06 print · Chairman and CEO
- Krogulski Kenneth 2025-04-29 · P · 7 days before the 2025-05-06 print
- Young Caroline 2025-04-29 · P · 7 days before the 2025-05-06 print
- Jones James 2025-04-30 · P · 6 days before the 2025-05-06 print
- KAZIMI A J 2025-04-30 · P · 6 days before the 2025-05-06 print · Chairman and CEO
- Krogulski Kenneth 2025-04-30 · P · 6 days before the 2025-05-06 print
- Young Caroline 2025-04-30 · P · 6 days before the 2025-05-06 print
- Jones James 2025-05-01 · P · 5 days before the 2025-05-06 print
- KAZIMI A J 2025-05-01 · P · 5 days before the 2025-05-06 print · Chairman and CEO
Adoption dates CUMBERLAND PHARMACEUTICALS INC states
- 2024-11-14 in 38 filings
Filing text: “10b5-1 trading plan adopted by the reporting person on November 14, 2024”
Reported results dates on file
- 2025-03-04
- 2025-05-06
- 2025-08-05
- 2025-11-04
- 2026-03-03
- 2026-05-05
- 2026-08-04
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.